Most Recent Episode
Treatment strategies and options in castration-resistant and advanced prostate cancer - PCD 2015 Lisbon

Treatment strategies and options in castration-resistant and advanced prostate cancer - PCD 2015 Lisbon

Prof Peter Mulders chairs an expert discussion with Prof Luis Costa , Prof Antonio Alcaraz and Prof Anwar Padhani to discuss changing practices when diagnosing and treating prostate cancer.
Time: 0:01
Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani
Prof Peter Mulders (Mount Vernon Cancer Centre, London, UK) chairs an expert discussion with Prof Luis Costa (Hospital de Santa Maria, Lisbon, Portugal), Prof Antonio Alcaraz (Medical Advantage Barcelona, Barcelona, Spain) and Prof Anwar Padhani (Institute of Cancer Research London, UK) to discuss changing practices when diagnosing and treating prostate cancer.
They cover the challenges faced when using bone scans and CT scans, and the practicalities of diagnosis using whole body MRI scans.
They also discuss the changing landscape of treatments and the role of chemotherapy in hormone sensitive disease effected by the results of trials such as STAMPEDE.
Episode ID: 1000356078218
GUID: CobaltPublic69/v4/d2/14/42/d2144296-9957-6b6b-074f-e599c18dd6dc/301-7233811345716833396-PCD_2015_Lisbon.mp4
Release Date: 01/11/2015, 13:13:00

Description

Prof Peter Mulders, Prof Luis Costa, Prof Antonio Alcaraz, Prof Anwar Padhani
Prof Peter Mulders (Mount Vernon Cancer Centre, London, UK) chairs an expert discussion with Prof Luis Costa (Hospital de Santa Maria, Lisbon, Portugal), Prof Antonio Alcaraz (Medical Advantage Barcelona, Barcelona, Spain) and Prof Anwar Padhani (Institute of Cancer Research London, UK) to discuss changing practices when diagnosing and treating prostate cancer.
They cover the challenges faced when using bone scans and CT scans, and the practicalities of diagnosis using whole body MRI scans.
They also discuss the changing landscape of treatments and the role of chemotherapy in hormone sensitive disease effected by the results of trials such as STAMPEDE.

Feed URL

Customer Reviews

No Entry